SARS-CoV-2-Specific T Cell Immunity in HIV-Associated Kaposi Sarcoma Patients in Zambia

Table 1

Baseline characteristics of study participants.

Median age in years	37.5 [32-42]
Males	17 (77.3%)
BMI in kg/m^2	24.3 [21.1-26.1]
CD4 count in cells/μl	199 [103-339]
HIV viral load in copies/ml	0 [0-42.5]
On ART	20 (90.9%)
Symptomatic for COVID19	1 (4.5%)
Vaccinated at baseline	2 (9.1%)
KS ACTG T1 stage	13 (59.1%)

BMI: body mass index in kg/m²; ART: antiretroviral therapy; KS: Kaposi sarcoma; ACTG: AIDS Clinical Trials Group.